- Home
- MBOT vs KZR Comparison
MBOT vs KZR Comparison
Compare MBOT & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBOT
- KZR
- Stock Information
- Founded
- MBOT 2010
- KZR 2015
- Country
- MBOT United States
- KZR United States
- Employees
- MBOT N/A
- KZR N/A
- Industry
- MBOT Medical/Dental Instruments
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- MBOT Health Care
- KZR Health Care
- Exchange
- MBOT Nasdaq
- KZR Nasdaq
- Market Cap
- MBOT 50.4M
- KZR 44.1M
- IPO Year
- MBOT N/A
- KZR 2018
- Fundamental
- Price
- MBOT $1.46
- KZR $4.94
- Analyst Decision
- MBOT Strong Buy
- KZR Hold
- Analyst Count
- MBOT 1
- KZR 2
- Target Price
- MBOT $9.00
- KZR $9.00
- AVG Volume (30 Days)
- MBOT 896.8K
- KZR 23.9K
- Earning Date
- MBOT 03-25-2025
- KZR 03-25-2025
- Dividend Yield
- MBOT N/A
- KZR N/A
- EPS Growth
- MBOT N/A
- KZR N/A
- EPS
- MBOT N/A
- KZR N/A
- Revenue
- MBOT N/A
- KZR N/A
- Revenue This Year
- MBOT N/A
- KZR N/A
- Revenue Next Year
- MBOT N/A
- KZR N/A
- P/E Ratio
- MBOT N/A
- KZR N/A
- Revenue Growth
- MBOT N/A
- KZR N/A
- 52 Week Low
- MBOT $0.82
- KZR $4.90
- 52 Week High
- MBOT $3.38
- KZR $9.30
- Technical
- Relative Strength Index (RSI)
- MBOT 42.47
- KZR 40.33
- Support Level
- MBOT $1.60
- KZR $5.52
- Resistance Level
- MBOT $1.81
- KZR $6.37
- Average True Range (ATR)
- MBOT 0.12
- KZR 0.29
- MACD
- MBOT 0.00
- KZR 0.01
- Stochastic Oscillator
- MBOT 22.22
- KZR 9.28
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.